soul trial oral semaglutide cardiovascular outcomes results benefit study in High-Risk Type 2 Diabetes: Confirmed in the Trial Scorecard: SOUL – Oral Semaglutide in High-Risk Type – The SOUL Study - by
Pay in 4 interest-free payments of $7.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25



























